7 Recruiting Mesothelioma Phase 1 Clinical Trials
Active phase 1 studies for mesothelioma enrolling across the USA. Verify eligibility and contact site coordinators.
All Mesothelioma studiesPhase 1 Studies for Mesothelioma
🔵 Active, Not Recruiting Phase1
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
📍 University of California LA — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
📍 Duke Cancer Institute — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase1
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A 2-part Phase 1/2 Open-label Trial on ODM-212
📍 NEXT Oncology — Irving, Texas
View Study & Checklist ➔